US-India trade pact: Overall pharmaceutical norms are consistent with the approach across FTAs, says IPA

SENSEX   83,580.40

+ 266.47

NIFTY   25,693.70

+ 50.90

CRUDEOIL   5,821.00

+ 75.00

GOLD   155,499.00

+ 3,428.00

SILVER   249,000.00

+ 5,185.00

Indian Pharmaceutical Alliance (IPA) has welcomed the interim-agreement between India and the United States.

“Strengthening the India–US medicines partnership is important, as medicine security is a part of national security. Generics are exempted from tariffs.,’’ Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA) said in a statement on Saturday.

“As noted in the Joint Statement, overall pharmaceuticals (including generics) are subject to ongoing US. Section 232 investigation. This is consistent with the approach across FTAs,’’ he said.

Published on February 7, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.